NCT/Study#

NCT04623775 /

CA224-104

A Study of Relatlimab plus Nivolumab in Combination with Chemotherapy vs. Nivolumab in Combination with Chemotherapy in Participants with Stage IV or Recurrent NSCLC

A Study of Relatlimab plus Nivolumab in Combination with Chemotherapy vs. Nivolumab in Combination with Chemotherapy in Participants with Stage IV or Recurrent NSCLC

DISEASE GROUP:
Lung
current phase:
II
STUDY STATUS:
Accepting Patients
Location:
Little Silver, NJ
For More information: